Note: One pack contains 4 pills.
|Pack Size||Qty||Price Per Pill or Unit||Price||Cart|
|12 Tablet/s||US$ 2.68||US$ 32.18|
|32 Tablet/s||US$ 2.70||US$ 86.24|
|64 Tablet/s||US$ 2.70||US$ 172.49|
|128 Tablet/s||US$ 2.70||US$ 344.99|
Risofos 35 mg
Risofos 35 mg is a medicine for bone disease and belongs to a group of medicines called bisphosphonates. It is once a weak tablet used to treat osteoporosis (brittle bones that may fracture easily). The medicine is also effective in treating osteoporosis caused by taking steroids. It works directly on your bones to increase their strength of the bones and, therefore less likely to break and fracture.
How to use
Regardless of the dose and how often it is taken, you will be instructed to take Risofos at least half an hour before your first food or drink. It is also important that you avoid any other medication during this time. If you are taking a calcium supplement, it is important to leave at least 3 to 4 hours after taking Risofos, as calcium will prevent its absorption. Your doctor may recommend a dose of 35 mg once weekly, taken on the same day each week. Remember, some mineral water from regional areas may have a higher calcium concentration and, therefore, should be avoided.
Patients should not chew this tablet because of an increased risk of oropharyngeal irritation. No dose adjustment is necessary for patients with mild to moderate renal insufficiency. Risedronate is not recommended for severe renal impairment.
Risofos is contraindicated in patients hypersensitive to this medicine or any other ingredients of this formulation. Also, it should not be given to patients with hypocalcaemia (deficiency of calcium in the bloodstream. Food, certain medications, and beverages (except plain water) can interfere with the absorption of Risedronate. Therefore, taking medicine as per the dosage instructions is best for patients to gain maximum benefits. This is especially important in the case of patients with a history of oesophageal disorders.
Like other bisphosphonates, Risofos may cause local irritation of the upper gastrointestinal tract. The class of medication have been associated with gastritis, esophagitis, gastroduodenal ulcerations, and oesophagal ulcerations. Thus, caution should be used in patients with a history of oesophagal disorders. Hypoglycemia (abnormally low blood sugar) must be corrected before starting Risedronate treatment. Bone and mineral dysfunctions such as vitamin D deficiency and parathyroid abnormalities should be effectively treated before starting the treatment. Patients should begin taking calcium and vitamin D supplements if dietary intake is not adequate.
As with any medicine, there are potential side effects with Risofos 35 mg. Although it is important to remember that most people will not experience side effects, or if they do, they are temporary and resolved within a few days. Symptoms reported by patients taking part in the research trials might be included as possible side effects even if they were seen in as many people who took part in clinical trials as those taking Risofos 35 mg. So common conditions such as constipation, diarrhoea, and nausea will often be reported.
The full list of these side effects can be obtained from the doctor. If you develop any other symptoms you think you may be having due to the use of Risedronate, speak to your doctor about alternative drug treatment.